1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsVirginia Catalyst Grant Funding Program is sponsored by Virginia Catalyst (Virginia Biosciences Health Research Corporation - VBHRC). This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Get emailed when new opportunities from “Virginia Catalyst (Virginia Biosciences Health Research Corporation - VBHRC)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
strength through collaboration Our Strategic Initiatives - Actions and Results for Virginia At the Virginia Catalyst we specialize in developing and leading strategic initiatives in areas were Virginia can be a national and global leader.
We support these initiatives with grant funding for collaborative projects, investments creating research tools, and infrastructure that provide our research universities, healthcare systems and companies a competitive advantage over other regions in the country. Our goal is to have the Commonwealth of Virginia be the very best in the nation at translational medicine and commercialization.
We will achieve this by teaming up the biosciences industry with our world-class academic researchers and focusing efforts on solving large unmet medical needs.
Continuing powerful impact through our Grant Funding Program Funding through our Grant Funding Program is designed to facilitate the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. Virginia Catalyst awards these funds to help accelerate translational research and the commercialization of Virginia’s innovations.
The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities. Learn more about our Grant Funding Program Special Webinar - How to Score High and Get Funding Previously the Virginia Catalyst and Virginia Bio co-hosted a special webinar that featured a panel of experts sharing what it takes to score highly and get funding.
Mike Grisham , President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc. Mickey Kim , former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute J ames Powers , Chairman and CEO, HemoShear Theapeutics, LLC Thomas D.
Roberts III , General Partner, Harbert Growth Partners, Harbert Management Corporation Read the full press release here Download the presentation slides We are a not-for-profit 501(c)(3) corporation created by the Virginia General Assembly and funded by the Commonwealth’s General Fund and five Virginia public research universities: George Mason University, Old Dominion University (with Eastern Virginia Medical School) , University of Virginia, Virginia Commonwealth University, and Virginia Tech.
Our mission is to advance economic development by creating competitive critical mass for Virginia life sciences through collaborations with our research universities and industry, to attract research and commercialization capital to Virginia and to catalyze the commercialization of Virginia’s innovations that meet large, unmet medical needs, improve human health and to create many more high-paying life science jobs in Virginia.
According to the current listing, eligibility includes: Collaborative efforts between industry and Virginia research universities. Confirm the full requirements in the official notice before applying.
The current listing shows $200,000 to $800,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Virginia Catalyst Grant Funding Program is funded by Virginia Catalyst (Virginia Biosciences Health Research Corporation - VBHRC). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Virginia. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
RWJF's Health Equity Research for Action puts up ~20 grants of up to $500,000 — but demands a two-year community partnership and a community co-PI. Here's the strategy, set against the brightest foundation-giving outlook since 2022.
Read articleCMS awarded all 50 states a slice of the $50 billion Rural Health Transformation Program on December 29, 2025 — first-year checks average $200M, ranging from $147M to $281M. The federal application is closed and you cannot apply to CMS. The money reaches hospitals, clinics, and nonprofits only as state subawards, and those competitions open through 2026. Here is how the formula worked, what the funds can and cannot buy, and how to position for a subaward before the money starts flowing.
Read articleCMS awarded the entire $50 billion Rural Health Transformation Program to all 50 states, with first-year checks averaging $200M per state and money starting to move October 1, 2026. The federal contest is over — but for rural hospitals, clinics, behavioral-health providers, and nonprofits, the real competition is just beginning inside each state's sub-grant process. Here is how the money splits, what it can fund, and how to position now.
Read article